Alan Silman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Alan Silman has a total of 203 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Prieto-Alhambra
Centre for Statistics in Medicine, NDORMS, University of Oxford, Oxford, UK
7 shared publications - Antonella Delmestri
University of Oxford
4 shared publications - Jose Maria Valderas
Department of Health & Community Sciences, Exeter Collaboration for Academic Primary Care (APEx), University of Exeter, Exeter, UK
4 shared publications Mark Lunt
Centre for Musculoskeletal Research, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK
4 shared publications- Nigel K. Arden
Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Oxford, UK
4 shared publications - Alexander James MacGregor
University of East Anglia
3 shared publications
Latest Publications
- Open Access
- 30 April 2026
- Published by International Society of Global Health in Journal of Global Health
- Vol. 16, 04098
Prevalence and types of lower limb conditions in Nepal
Understanding the burden and pattern of health conditions is vital for health systems to plan services and allocate resources effectively. In many low- and middle-income countries (LMICs), data are limited and often derived from Global Burden of Disease (GBD) estimates, which rely on broad categories of conditions [1]. This can obscure the lived realities […]
- 30 April 2026
- Published by International Society of Global Health in Journal of Global Health
- Vol. 16, 04098
Open AccessPrevalence and types of lower limb conditions in Nepal
Understanding the burden and pattern of health conditions is vital for health systems to plan services and allocate resources effectively. In many low- and middle-income countries (LMICs), data are limited and often derived from Global Burden of Disease (GBD) estimates, which rely on broad categories of conditions [1]. This can obscure the lived realities […]
- Open Access
Prevalence and types of lower limb conditions in Nepal
Background: Understanding the burden of lower limb conditions (LLCs) is essential for effective health planning, yet data in low-resource settings like Nepal is scarce. LLCs, encompassing diverse issues such as pain, injuries and amputations, can profoundly impact mobility, well-being, and livelihoods. With limited healthcare access and growing non-communicable diseases, the scale and impact of LLCs in Nepal remain unknown. This study estimates the prevalence and distribution of person-reported LLCs, exploring their effects on daily living and regional disparities. Methods: To estimate the prevalence of LLCs a household survey was conducted in three selected districts of Nepal representing different ecological zones; Dolakha (Mountain), Lamjung (Hill) and Dang (Terai/Plan). Follow-up questions to 500 individuals with LLCs explored the conditions further, including their distribution by cause and by important characteristics at the individual and ecological zone levels. Results: A total of 2,525 households were surveyed and screened for LLCs. Six hundred and seventy one (26%) of households reported that there was at least one person with an LLC, and at the individual level 11.2% of adults reported an LLC. Sixty-five percent of LLC sufferers were women. Pain and discomfort was the most common problem (reported in 97% of those with an LLC), followed by injury/trauma (19%), deformity (7.2%), wounds (1.4%) and amputation (0.8%). We present the regions of the lower limb most affected, causes of conditions and the extent to which each condition affected participants’ ability to carry out activities of daily living. Conclusion: Our study shows a high prevalence of LLCs across diverse regions of Nepal, with pain and discomfort most frequently reported, and injuries and trauma common in specific areas. LLCs impair daily activities and employment, highlighting the need for tailored interventions and assistive technologies. Findings pave the way for larger-scale studies and scalable, cost-effective solutions.
Open AccessPrevalence and types of lower limb conditions in Nepal
Background: Understanding the burden of lower limb conditions (LLCs) is essential for effective health planning, yet data in low-resource settings like Nepal is scarce. LLCs, encompassing diverse issues such as pain, injuries and amputations, can profoundly impact mobility, well-being, and livelihoods. With limited healthcare access and growing non-communicable diseases, the scale and impact of LLCs in Nepal remain unknown. This study estimates the prevalence and distribution of person-reported LLCs, exploring their effects on daily living and regional disparities. Methods: To estimate the prevalence of LLCs a household survey was conducted in three selected districts of Nepal representing different ecological zones; Dolakha (Mountain), Lamjung (Hill) and Dang (Terai/Plan). Follow-up questions to 500 individuals with LLCs explored the conditions further, including their distribution by cause and by important characteristics at the individual and ecological zone levels. Results: A total of 2,525 households were surveyed and screened for LLCs. Six hundred and seventy one (26%) of households reported that there was at least one person with an LLC, and at the individual level 11.2% of adults reported an LLC. Sixty-five percent of LLC sufferers were women. Pain and discomfort was the most common problem (reported in 97% of those with an LLC), followed by injury/trauma (19%), deformity (7.2%), wounds (1.4%) and amputation (0.8%). We present the regions of the lower limb most affected, causes of conditions and the extent to which each condition affected participants’ ability to carry out activities of daily living. Conclusion: Our study shows a high prevalence of LLCs across diverse regions of Nepal, with pain and discomfort most frequently reported, and injuries and trauma common in specific areas. LLCs impair daily activities and employment, highlighting the need for tailored interventions and assistive technologies. Findings pave the way for larger-scale studies and scalable, cost-effective solutions.
- Open Access
- 26 June 2024
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 173, 111442
Longitudinal trajectories of frailty are associated with short-term mortality in older people: a joint latent class models analysis using 2 UK primary care databases
- 26 June 2024
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 173, 111442
Open AccessLongitudinal trajectories of frailty are associated with short-term mortality in older people: a joint latent class models analysis using 2 UK primary care databases
- Open Access
- 7 May 2022
- Published by Wiley in Journal of Foot and Ankle Research
- Vol. 15 (1) , 1-7
Survival of primary ankle replacements: data from global joint registries
Background: Ankle arthroplasty, commonly known as ankle replacement, is a surgical procedure for treating end‐stage ankle osteoarthritis. Whilst evidence shows good clinical results after surgery, little is known of the long‐term survival of ankle replacements and the need for ankle revision. Using more recent implant data and long‐term data, there is now opportunity to examine at a population‐level the survival rate for ankle implants, to examine between‐country differences in ankle revision surgery, and to compare temporal trends in revision rates between countries.Methods: Four national joint registries from Australia, New Zealand, Norway and Sweden provided the necessary data on revision outcome following primary ankle replacement, for various periods of observation – the earliest starting in 1993 up to the end of 2019. Data were either acquired from published, online annual reports or were provided from direct contact with the joint registries. The key information extracted were Kaplan‐Meier estimates to plot survival probability curves following primary ankle replacement.Results: The survival rates varied between countries. At 2 years, across all registries, survival rates all exceeded 0.9 (range 0.91 to 0.97). The variation widened at 5 years (range 0.80 to 0.91), at 10 years (range 0.66 to 0.84) and further at 15‐years follow‐up (0.56 to 0.78). At each time point, implant survival was greater in Australia and New Zealand with lower rates in Sweden and Norway.Conclusions: We observed variation in primary ankle replacement survival rates across these national registries, although even after 5 years, these population derived data show an 80% revision free survival. These data raise a number of hypotheses concerning the reasons for between‐country differences in revision‐free survival which will require access to primary data for analysis.
- 7 May 2022
- Published by Wiley in Journal of Foot and Ankle Research
- Vol. 15 (1) , 1-7
Open AccessSurvival of primary ankle replacements: data from global joint registries
Background: Ankle arthroplasty, commonly known as ankle replacement, is a surgical procedure for treating end‐stage ankle osteoarthritis. Whilst evidence shows good clinical results after surgery, little is known of the long‐term survival of ankle replacements and the need for ankle revision. Using more recent implant data and long‐term data, there is now opportunity to examine at a population‐level the survival rate for ankle implants, to examine between‐country differences in ankle revision surgery, and to compare temporal trends in revision rates between countries.Methods: Four national joint registries from Australia, New Zealand, Norway and Sweden provided the necessary data on revision outcome following primary ankle replacement, for various periods of observation – the earliest starting in 1993 up to the end of 2019. Data were either acquired from published, online annual reports or were provided from direct contact with the joint registries. The key information extracted were Kaplan‐Meier estimates to plot survival probability curves following primary ankle replacement.Results: The survival rates varied between countries. At 2 years, across all registries, survival rates all exceeded 0.9 (range 0.91 to 0.97). The variation widened at 5 years (range 0.80 to 0.91), at 10 years (range 0.66 to 0.84) and further at 15‐years follow‐up (0.56 to 0.78). At each time point, implant survival was greater in Australia and New Zealand with lower rates in Sweden and Norway.Conclusions: We observed variation in primary ankle replacement survival rates across these national registries, although even after 5 years, these population derived data show an 80% revision free survival. These data raise a number of hypotheses concerning the reasons for between‐country differences in revision‐free survival which will require access to primary data for analysis.
- 28 March 2022
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 30, S252-S253
UPDATED PREDICTION MODEL FOR PROGRESSIVE RADIOGRAPHIC FINGER INTERPHALANGEAL JOINT OSTEOARTHRITIS
- 28 March 2022
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 30, S252-S253
UPDATED PREDICTION MODEL FOR PROGRESSIVE RADIOGRAPHIC FINGER INTERPHALANGEAL JOINT OSTEOARTHRITIS
- 1 November 2021
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 25 (66) , 1-126
Unicompartmental compared with total knee replacement for patients with multimorbidities: a cohort study using propensity score stratification and inverse probability weighting
Background: Although routine NHS data potentially include all patients, confounding limits their use for causal inference. Methods to minimise confounding in observational studies of implantable devices are required to enable the evaluation of patients with severe systemic morbidity who are excluded from many randomised controlled trials. Objectives: Stage 1 – replicate the Total or Partial Knee Arthroplasty Trial (TOPKAT), a surgical randomised controlled trial comparing unicompartmental knee replacement with total knee replacement using propensity score and instrumental variable methods. Stage 2 – compare the risk benefits and cost-effectiveness of unicompartmental knee replacement with total knee replacement surgery in patients with severe systemic morbidity who would have been ineligible for TOPKAT using the validated methods from stage 1. Design: This was a cohort study. Setting: Data were obtained from the National Joint Registry database and linked to hospital inpatient (Hospital Episode Statistics) and patient-reported outcome data. Participants: Stage 1 – people undergoing unicompartmental knee replacement surgery or total knee replacement surgery who met the TOPKAT eligibility criteria. Stage 2 – participants with an American Society of Anesthesiologists grade of ≥ 3. Intervention: The patients were exposed to either unicompartmental knee replacement surgery or total knee replacement surgery. Main outcome measures: The primary outcome measure was the postoperative Oxford Knee Score. The secondary outcome measures were 90-day postoperative complications (venous thromboembolism, myocardial infarction and prosthetic joint infection) and 5-year revision risk and mortality. The main outcome measures for the health economic analysis were health-related quality of life (EuroQol-5 Dimensions) and NHS hospital costs. Results: In stage 1, propensity score stratification and inverse probability weighting replicated the results of TOPKAT. Propensity score adjustment, propensity score matching and instrumental variables did not. Stage 2 included 2256 unicompartmental knee replacement patients and 57,682 total knee replacement patients who had severe comorbidities, of whom 145 and 23,344 had linked Oxford Knee Scores, respectively. A statistically significant but clinically irrelevant difference favouring unicompartmental knee replacement was observed, with a mean postoperative Oxford Knee Score difference of < 2 points using propensity score stratification; no significant difference was observed using inverse probability weighting. Unicompartmental knee replacement more than halved the risk of venous thromboembolism [relative risk 0.33 (95% confidence interval 0.15 to 0.74) using propensity score stratification; relative risk 0.39 (95% confidence interval 0.16 to 0.96) using inverse probability weighting]. Unicompartmental knee replacement was not associated with myocardial infarction or prosthetic joint infection using either method. In the long term, unicompartmental knee replacement had double the revision risk of total knee replacement [hazard ratio 2.70 (95% confidence interval 2.15 to 3.38) using propensity score stratification; hazard ratio 2.60 (95% confidence interval 1.94 to 3.47) using inverse probability weighting], but half of the mortality [hazard ratio 0.52 (95% confidence interval 0.36 to 0.74) using propensity score stratification; insignificant effect using inverse probability weighting]. Unicompartmental knee replacement had lower costs and higher quality-adjusted life-year gains than total knee replacement for stage 2 participants. Limitations: Although some propensity score methods successfully replicated TOPKAT, unresolved confounding may have affected stage 2. Missing Oxford Knee Scores may have led to information bias. Conclusions: Propensity score stratification and inverse probability weighting successfully replicated TOPKAT, implying that some (but not all) propensity score methods can be used to evaluate surgical innovations and implantable medical devices using routine NHS data. Unicompartmental knee replacement was safer and more cost-effective than total knee replacement for patients with severe comorbidity and should be considered the first option for suitable patients. Future work: Further research is required to understand the performance of propensity score methods for evaluating surgical innovations and implantable devices. Trial registration: This trial is registered as EUPAS17435. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 25, No. 66. See the NIHR Journals Library website for further project information.
- 1 November 2021
- Published by National Institute for Health and Care Research in Health Technology Assessment
- Vol. 25 (66) , 1-126
Unicompartmental compared with total knee replacement for patients with multimorbidities: a cohort study using propensity score stratification and inverse probability weighting
Background: Although routine NHS data potentially include all patients, confounding limits their use for causal inference. Methods to minimise confounding in observational studies of implantable devices are required to enable the evaluation of patients with severe systemic morbidity who are excluded from many randomised controlled trials. Objectives: Stage 1 – replicate the Total or Partial Knee Arthroplasty Trial (TOPKAT), a surgical randomised controlled trial comparing unicompartmental knee replacement with total knee replacement using propensity score and instrumental variable methods. Stage 2 – compare the risk benefits and cost-effectiveness of unicompartmental knee replacement with total knee replacement surgery in patients with severe systemic morbidity who would have been ineligible for TOPKAT using the validated methods from stage 1. Design: This was a cohort study. Setting: Data were obtained from the National Joint Registry database and linked to hospital inpatient (Hospital Episode Statistics) and patient-reported outcome data. Participants: Stage 1 – people undergoing unicompartmental knee replacement surgery or total knee replacement surgery who met the TOPKAT eligibility criteria. Stage 2 – participants with an American Society of Anesthesiologists grade of ≥ 3. Intervention: The patients were exposed to either unicompartmental knee replacement surgery or total knee replacement surgery. Main outcome measures: The primary outcome measure was the postoperative Oxford Knee Score. The secondary outcome measures were 90-day postoperative complications (venous thromboembolism, myocardial infarction and prosthetic joint infection) and 5-year revision risk and mortality. The main outcome measures for the health economic analysis were health-related quality of life (EuroQol-5 Dimensions) and NHS hospital costs. Results: In stage 1, propensity score stratification and inverse probability weighting replicated the results of TOPKAT. Propensity score adjustment, propensity score matching and instrumental variables did not. Stage 2 included 2256 unicompartmental knee replacement patients and 57,682 total knee replacement patients who had severe comorbidities, of whom 145 and 23,344 had linked Oxford Knee Scores, respectively. A statistically significant but clinically irrelevant difference favouring unicompartmental knee replacement was observed, with a mean postoperative Oxford Knee Score difference of < 2 points using propensity score stratification; no significant difference was observed using inverse probability weighting. Unicompartmental knee replacement more than halved the risk of venous thromboembolism [relative risk 0.33 (95% confidence interval 0.15 to 0.74) using propensity score stratification; relative risk 0.39 (95% confidence interval 0.16 to 0.96) using inverse probability weighting]. Unicompartmental knee replacement was not associated with myocardial infarction or prosthetic joint infection using either method. In the long term, unicompartmental knee replacement had double the revision risk of total knee replacement [hazard ratio 2.70 (95% confidence interval 2.15 to 3.38) using propensity score stratification; hazard ratio 2.60 (95% confidence interval 1.94 to 3.47) using inverse probability weighting], but half of the mortality [hazard ratio 0.52 (95% confidence interval 0.36 to 0.74) using propensity score stratification; insignificant effect using inverse probability weighting]. Unicompartmental knee replacement had lower costs and higher quality-adjusted life-year gains than total knee replacement for stage 2 participants. Limitations: Although some propensity score methods successfully replicated TOPKAT, unresolved confounding may have affected stage 2. Missing Oxford Knee Scores may have led to information bias. Conclusions: Propensity score stratification and inverse probability weighting successfully replicated TOPKAT, implying that some (but not all) propensity score methods can be used to evaluate surgical innovations and implantable medical devices using routine NHS data. Unicompartmental knee replacement was safer and more cost-effective than total knee replacement for patients with severe comorbidity and should be considered the first option for suitable patients. Future work: Further research is required to understand the performance of propensity score methods for evaluating surgical innovations and implantable devices. Trial registration: This trial is registered as EUPAS17435. Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 25, No. 66. See the NIHR Journals Library website for further project information.
- Open Access
Influence of pre-existing multimorbidity on receiving a hip arthroplasty: cohort study of 28 025 elderly subjects from UK primary care
The median age for total hip arthroplasty (THA) is over 70 years with the corollary that many individuals have multiple multimorbidities. Despite the predicted improvement in quality of life, THA might be denied even to those with low levels of multimorbidity. Objective To evaluate how pre-existing levels of multimorbidity influence the likelihood and timing of THA. Setting Longitudinal record linkage study of a UK sample linking their primary care to their secondary care records. Participants A total of 28 025 patients were included, based on the recording of the diagnosis of hip osteoarthritis in a national primary care register, Clinical Practice Research Datalink. Data were extracted from the database on background health and morbidity status using five different constructs: Charlson Comorbidity Index, Electronic Frailty Index and counts of chronic diseases (from list of 17), prescribed medications and number of primary care visits prior to recording of osteoarthritis. Outcome measures The record of having received a THA as recorded in the primary care record and the linked secondary care database: Hospital Episode Statistics. Results 40% had THA: median follow 10 months (range 1–17 years). Increased multimorbidity was associated with a decreased likelihood of undergoing THA, irrespective of the method of assessing multimorbidity although the impact varied by approach. Conclusion Markers of pre-existing ill health influence the decision for THA in the elderly with end-stage hip osteoarthritis, although these effects are modest for indices of multimorbidity other than eFI. There is evidence of this influence being present even in people with moderate decrements in their health, despite the balance of benefits to risk in these individuals being positive.
Open AccessInfluence of pre-existing multimorbidity on receiving a hip arthroplasty: cohort study of 28 025 elderly subjects from UK primary care
The median age for total hip arthroplasty (THA) is over 70 years with the corollary that many individuals have multiple multimorbidities. Despite the predicted improvement in quality of life, THA might be denied even to those with low levels of multimorbidity. Objective To evaluate how pre-existing levels of multimorbidity influence the likelihood and timing of THA. Setting Longitudinal record linkage study of a UK sample linking their primary care to their secondary care records. Participants A total of 28 025 patients were included, based on the recording of the diagnosis of hip osteoarthritis in a national primary care register, Clinical Practice Research Datalink. Data were extracted from the database on background health and morbidity status using five different constructs: Charlson Comorbidity Index, Electronic Frailty Index and counts of chronic diseases (from list of 17), prescribed medications and number of primary care visits prior to recording of osteoarthritis. Outcome measures The record of having received a THA as recorded in the primary care record and the linked secondary care database: Hospital Episode Statistics. Results 40% had THA: median follow 10 months (range 1–17 years). Increased multimorbidity was associated with a decreased likelihood of undergoing THA, irrespective of the method of assessing multimorbidity although the impact varied by approach. Conclusion Markers of pre-existing ill health influence the decision for THA in the elderly with end-stage hip osteoarthritis, although these effects are modest for indices of multimorbidity other than eFI. There is evidence of this influence being present even in people with moderate decrements in their health, despite the balance of benefits to risk in these individuals being positive.
- Open Access
Does pre-existing morbidity influences risks and benefits of total hip replacement for osteoarthritis: a prospective study of 6682 patients from linked national datasets in England
Total hip arthroplasty (THA) surgery for elderly people with multimorbidity increases the risk of serious health hazards including mortality. Whether such background morbidity reduces the clinical benefit is less clear. Objective To evaluate how pre-existing health status, using multiple approaches, influences risks of, and quality of life benefits from, THA. Setting Longitudinal record linkage study of a UK sample linking their primary care to their secondary care records. Participants A total of 6682 patients were included, based on the recording of the diagnosis of hip osteoarthritis in a national primary care register and the recording of the receipt of THA in a national secondary care register. Data were extracted from the primary care register on background health and morbidity status using five different constructs: Charlson Comorbidity Index, Electronic Frailty Index (eFI) and counts of comorbidity disorders (from list of 17), prescribed medications and number of primary care visits prior to recording of THA. Outcome measures (1) Postoperative complications and mortality; (2) postoperative hip pain and function using the Oxford Hip Score (OHS) and health-related quality of life using the EuroQoL (EQ)-5D score. Results Perioperative complication rate was 3.2% and mortality was 0.9%, both increased with worse preoperative health status although this relationship varied depending on the morbidity construct: the eFI showing the strongest relationship but number of visits having no predictive value. By contrast, the benefits were not reduced in those with worse preoperative health, and improvement in both OHS and EQ-5D was observed in all the morbidity categories. Conclusions Independent of preoperative morbidity, THA leads to similar substantial improvements in quality of life. These are offset by an increase in medical complications in some subgroups of patients with high morbidity, depending on the definition used. For most elderly people, their other health disorders should not be a barrier for THA.
Open AccessDoes pre-existing morbidity influences risks and benefits of total hip replacement for osteoarthritis: a prospective study of 6682 patients from linked national datasets in England
Total hip arthroplasty (THA) surgery for elderly people with multimorbidity increases the risk of serious health hazards including mortality. Whether such background morbidity reduces the clinical benefit is less clear. Objective To evaluate how pre-existing health status, using multiple approaches, influences risks of, and quality of life benefits from, THA. Setting Longitudinal record linkage study of a UK sample linking their primary care to their secondary care records. Participants A total of 6682 patients were included, based on the recording of the diagnosis of hip osteoarthritis in a national primary care register and the recording of the receipt of THA in a national secondary care register. Data were extracted from the primary care register on background health and morbidity status using five different constructs: Charlson Comorbidity Index, Electronic Frailty Index (eFI) and counts of comorbidity disorders (from list of 17), prescribed medications and number of primary care visits prior to recording of THA. Outcome measures (1) Postoperative complications and mortality; (2) postoperative hip pain and function using the Oxford Hip Score (OHS) and health-related quality of life using the EuroQoL (EQ)-5D score. Results Perioperative complication rate was 3.2% and mortality was 0.9%, both increased with worse preoperative health status although this relationship varied depending on the morbidity construct: the eFI showing the strongest relationship but number of visits having no predictive value. By contrast, the benefits were not reduced in those with worse preoperative health, and improvement in both OHS and EQ-5D was observed in all the morbidity categories. Conclusions Independent of preoperative morbidity, THA leads to similar substantial improvements in quality of life. These are offset by an increase in medical complications in some subgroups of patients with high morbidity, depending on the definition used. For most elderly people, their other health disorders should not be a barrier for THA.
- 1 October 2019
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 27 (10) , 1430-1436
The different influence of high levels of physical activity on the incidence of knee OA in overweight and obese men and women-a gender specific analysis
- 1 October 2019
- Published by Elsevier in Osteoarthritis and Cartilage
- Vol. 27 (10) , 1430-1436
The different influence of high levels of physical activity on the incidence of knee OA in overweight and obese men and women-a gender specific analysis
- Open Access
- 23 May 2019
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 58 (11) , 2078
Lifetime risk of knee and hip replacement following a diagnosis of RA: findings from a cohort of 13 961 patients from England
- 23 May 2019
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 58 (11) , 2078
Open AccessLifetime risk of knee and hip replacement following a diagnosis of RA: findings from a cohort of 13 961 patients from England